Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pegylated proline-interferon alpha-2b

EU orphan designation number: EU/3/11/932   
Active ingredient: Pegylated proline-interferon alpha-2b
Indication: Treatment of polycythaemia vera
Sponsor: AOP Orphan Pharmaceuticals AG
Wilhelminenstraße 91/IIf/B4, A-1160 Wien, Österreich

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/12/2011 Centralised Orphan - Designation EMA/OD/055/11 (2011)9418 of 09/12/2011